CC - Company ID 0001627223
The table below shows Chemours Co's income statement line items across its last 6 fiscal years, exactly as reported in the company's audited annual filings. All figures are in US dollars; negative values appear in red.
| Line item | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 |
|---|---|---|---|---|---|---|
| Revenue | $5.81B | $5.78B | $6.08B | $6.83B | $6.34B | $4.97B |
| Cost of revenue | $4.91B | $4.64B | $4.78B | $5.21B | $4.96B | $3.90B |
| Gross profit | $902.00M | $1.14B | $1.30B | $1.62B | $1.38B | $1.07B |
| R&D | $108.00M | $109.00M | $108.00M | $118.00M | $107.00M | $93.00M |
Chemours Co reported annual revenue of $5.81B for fiscal year 2025. That is up 0.4% from $5.78B in fiscal 2024. Over the 10 fiscal years shown, annual revenue grew from $5.40B (FY 2016) to $5.81B. Figures come from the company's audited annual reports as filed with the SEC.
Data parsed from SEC EDGAR XBRL filings. See the full market cap rankings.
| SG&A |
| $799.00M |
| $598.00M |
| $1.29B |
| $710.00M |
| $592.00M |
| $527.00M |
| Operating income | - | - | - | - | - | - |
| Income tax | $109.00M | $37.00M | -$66.00M | $163.00M | $68.00M | -$40.00M |
| Net income | -$386.00M | $69.00M | -$253.00M | $578.00M | $608.00M | $219.00M |
| EPS (diluted) | -$2.57 | $0.46 | -$1.70 | $3.65 | $3.60 | $1.32 |